Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

References for PMC Articles for PubMed (Select 21947271)

1.

Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study.

Termuhlen AM, Tersak JM, Liu Q, Yasui Y, Stovall M, Weathers R, Deutsch M, Sklar CA, Oeffinger KC, Armstrong G, Robison LL, Green DM.

Pediatr Blood Cancer. 2011 Dec 15;57(7):1210-6. doi: 10.1002/pbc.23090. Epub 2011 Mar 7.

PMID:
21384541
2.

Long-term cause-specific mortality among survivors of childhood cancer.

Reulen RC, Winter DL, Frobisher C, Lancashire ER, Stiller CA, Jenney ME, Skinner R, Stevens MC, Hawkins MM; British Childhood Cancer Survivor Study Steering Group.

JAMA. 2010 Jul 14;304(2):172-9. doi: 10.1001/jama.2010.923.

PMID:
20628130
3.

Pregnancy outcome after treatment for Wilms tumor: a report from the national Wilms tumor long-term follow-up study.

Green DM, Lange JM, Peabody EM, Grigorieva NN, Peterson SM, Kalapurakal JA, Breslow NE.

J Clin Oncol. 2010 Jun 10;28(17):2824-30. doi: 10.1200/JCO.2009.27.2922. Epub 2010 May 10.

4.

Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose.

Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson AD.

Pediatr Blood Cancer. 2010 Jul 1;54(7):983-9. doi: 10.1002/pbc.22364.

PMID:
20405516
5.

Secondary malignant neoplasms after Wilms tumor: an international collaborative study.

Breslow NE, Lange JM, Friedman DL, Green DM, Hawkins MM, Murphy MF, Neglia JP, Olsen JH, Peterson SM, Stiller CA, Robison LL.

Int J Cancer. 2010 Aug 1;127(3):657-66. doi: 10.1002/ijc.25067.

6.

Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb).

Jennes I, Pedrini E, Zuntini M, Mordenti M, Balkassmi S, Asteggiano CG, Casey B, Bakker B, Sangiorgi L, Wuyts W.

Hum Mutat. 2009 Dec;30(12):1620-7. doi: 10.1002/humu.21123. Review.

PMID:
19810120
7.

Cardiac or cardiopulmonary transplantation in childhood cancer survivors: an increasing need?

Levitt G, Anazodo A, Burch M, Bunch K.

Eur J Cancer. 2009 Nov;45(17):3027-34. doi: 10.1016/j.ejca.2009.08.006. Epub 2009 Sep 8.

PMID:
19744853
8.

Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study.

Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, Mertens AC.

J Clin Oncol. 2009 May 10;27(14):2328-38. doi: 10.1200/JCO.2008.21.1425. Epub 2009 Mar 30. Review.

9.

Social outcomes in the Childhood Cancer Survivor Study cohort.

Gurney JG, Krull KR, Kadan-Lottick N, Nicholson HS, Nathan PC, Zebrack B, Tersak JM, Ness KK.

J Clin Oncol. 2009 May 10;27(14):2390-5. doi: 10.1200/JCO.2008.21.1458. Epub 2009 Feb 17. Review.

10.

Early and late mortality after diagnosis of wilms tumor.

Cotton CA, Peterson S, Norkool PA, Takashima J, Grigoriev Y, Green DM, Breslow NE.

J Clin Oncol. 2009 Mar 10;27(8):1304-9. doi: 10.1200/JCO.2008.18.6981. Epub 2009 Jan 12. Erratum in: J Clin Oncol. 2009 Oct 1;27(28):4819. Green, Daniel M [added].

11.

Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour.

Daw NC, Gregornik D, Rodman J, Marina N, Wu J, Kun LE, Jenkins JJ, McPherson V, Wilimas J, Jones DP.

Eur J Cancer. 2009 Jan;45(1):99-106. doi: 10.1016/j.ejca.2008.09.017. Epub 2008 Nov 6.

12.

Scholastic achievement of children with lymphoma or Wilms tumor at the end of comprehensive education--a nationwide, register-based study.

Lähteenmäki PM, Sankila R, Pukkala E, Kyyrönen P, Harila-Saari A.

Int J Cancer. 2008 Nov 15;123(10):2401-5. doi: 10.1002/ijc.23753.

PMID:
18651572
13.

Second primary neoplasms in survivors of Wilms' tumour--a population-based cohort study from the British Childhood Cancer Survivor Study.

Taylor AJ, Winter DL, Pritchard-Jones K, Stiller CA, Frobisher C, Lancashire ER, Reulen RC, Hawkins MM; British Childhood Cancer Survivor Study.

Int J Cancer. 2008 May 1;122(9):2085-93. doi: 10.1002/ijc.23333.

PMID:
18196579
14.

Does ifosfamide affect gonadal function?

Williams D, Crofton PM, Levitt G.

Pediatr Blood Cancer. 2008 Feb;50(2):347-51.

PMID:
17973323
15.

Medical assessment of adverse health outcomes in long-term survivors of childhood cancer.

Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, Jaspers MW, Koning CC, Oldenburger F, Langeveld NE, Hart AA, Bakker PJ, Caron HN, van Leeuwen FE.

JAMA. 2007 Jun 27;297(24):2705-15.

PMID:
17595271
16.

Employment status among adult survivors in the Childhood Cancer Survivor Study.

Pang JW, Friedman DL, Whitton JA, Stovall M, Mertens AC, Robison LL, Weiss NS.

Pediatr Blood Cancer. 2008 Jan;50(1):104-10.

PMID:
17554791
17.

Health-status of adult survivors of childhood cancer: a large-scale population-based study from the British Childhood Cancer Survivor Study.

Reulen RC, Winter DL, Lancashire ER, Zeegers MP, Jenney ME, Walters SJ, Jenkinson C, Hawkins MM.

Int J Cancer. 2007 Aug 1;121(3):633-40.

PMID:
17405119
18.

Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System.

Stöhr W, Paulides M, Bielack S, Jürgens H, Treuner J, Rossi R, Langer T, Beck JD.

Pediatr Blood Cancer. 2007 Apr;48(4):447-52.

PMID:
16628552
19.

End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System.

Breslow NE, Collins AJ, Ritchey ML, Grigoriev YA, Peterson SM, Green DM.

J Urol. 2005 Nov;174(5):1972-5.

20.

Success of clinical trials in childhood Wilms' tumour around the world.

Pritchard-Jones K, Pritchard J.

Lancet. 2004 Oct 23-29;364(9444):1468-70. No abstract available.

PMID:
15500874
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk